Exemptia 40mg Адалимумаб

WHAT IS EXEMPTIA Exemptia?

Adalimumab  is a potent TNF inhibitor and anti-inflammatory drug manufactured by Zydus Cadila. It binds to tumor necrosis factor-alpha (TNF). TNF usually binds to TNF receptors, leading to an inflammatory response in autoimmune diseases. By binding to TNF? ,  Exemptia  reduces this inflammatory response. A TNF inhibitor affects the  body's defense system, that is, the immune system  that protects the body from infection.

SCOPE Exemptia

Exemptia 40 mg pre-filled syringe is used to treat certain types of  arthritis  (an inflammatory condition  that usually affects the small joints in the hands and feet),  including -

• Ulcerative colitis: a  disease  that causes an ulcer on the lining of the colon.
• Crohn's disease:  Serious inflammation of the  gastrointestinal tract.
• Rheumatoid Arthritis (RA)  : This is a long-term autoimmune disease  that causes pain, swelling, stiffness, and loss of function in the joints. It can affect  any joint,  but is common in the wrist and fingers.
• Psoriatic Arthritis:  This happens because  your immune system is overactive. It mainly affects  people  who have psoriasis, a skin disease  that is also related to the immune system.
• Ankylosing spondylitis:  Inflammatory arthritis affects the spine and large joints.
• Plaque psoriasis:  Plaque psoriasis is a chronic autoimmune condition. It appears on the skin in areas of thick, red, scaly skin.
• Juvenile idiopathic arthritis:  Juvenile idiopathic arthritis (JIA), also known as juvenile rheumatoid arthritis (JRA), is currently the most widely accepted term to describe various types of